Agimexpharm Pharmaceutical Joint Stock Company
Similar suppliers you may like
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
4
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt
Can Gio Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
1982301-500 peopleManufacturer/Trading CompanyEstablished brand
OEM manufacturer
Key market
🇻🇳 Vietnam
Description
Can Gio Pharmaceutical Joint Stock Company (Cagipharm) is a prominent Vietnamese manufacturer and trading company established in 1982. Headquartered in Ho Chi Minh City and listed on the UPCOM stock exchange, the company operates with a workforce of approximately 395 to 500 employees. It maintains a diversified business structure through subsidiaries such as Us Pharma Usa Joint Stock Company and International Hospital Joint Stock Company, reflecting its significant scale within the regional healthcare sector.
CADIGESIC Caplet 500
Giải Độc Gan
Giảm Cân
Nghệ Nano
Dưỡng Trắng Da
USgout
BỔ THẬN DƯƠNG
ĐẠI TRÀNG
TRINH NỮ HOÀNG CUNG
Alpha-tase
CADIMIN MULTI
BETACLO
